STAT January 17, 2025
Rachel Cohrs Zhang

15 drugs for conditions like cancer included in second round of price talks

WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic and Wegovy, further complicating big decisions the Trump administration will have to make about how to cover the medications.

The drugs are on a list of 15 whose prices will be negotiated this year in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Insurance, Medicare, Pharma, Pharma / Biotech
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Congressional Medicare advisors recommend tying radiologist pay increases to inflation
Medicare's new $2,000 cap on out-of-pocket drug costs could save patients thousands, AARP says
Prescription drug cap may save Medicare enrollees thousands: Report
MedPAC recommends to Congress Medicare 2026 payment updates for inpatient, outpatient services

Share This Article